EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer

About 70% of all breast cancers are estrogen receptor alpha positive (ER+; ESR1). Many are treated with antiestrogens. Unfortunately, de novo and acquired resistance to antiestrogens is common but the underlying mechanisms remain unclear. Since growth of cancer cells is dependent on adequate energy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Shajahan-Haq, Ayesha N., Boca, Simina M., Jin, Lu, Bhuvaneshwar, Krithika, Gusev, Yuriy, Cheema, Amrita K., Demas, Diane D., Raghavan, Kristopher S., Michalek, Ryan, Madhavan, Subha, Clarke, Robert
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5722529/
https://ncbi.nlm.nih.gov/pubmed/29228577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18292
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados